GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$172.31
+2.89%Margins
Gross margin
79.9%
EBITDA margin
2.7%
EBIT margin
-4.4%
Net margin
-12.5%
FCF margin
45.3%
-29.6%
Return on equity
-7.5%
Return on assets
-3.5%
Return on invested capital
0.61x
Asset turnover
$14.5B
Cash from operations
$5.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026